Abstract. In November 2013, a Plasmodium falciparum malaria outbreak of 11 cases occurred in Cusco, southern Peru, where falciparum malaria had not been reported since 1946. Although initial microscopic diagnosis reported only Plasmodium vivax infection in each of the specimens, subsequent examination by the national reference laboratory confirmed P. falciparum infection in all samples. Molecular typing of four available isolates revealed identity as the B-variant (B V1 ) strain that was responsible for a malaria outbreak in Tumbes, northern Peru, between 2010 and 2012. The P. falciparum B V1 strain is multidrug resistant, can escape detection by PfHRP2-based rapid diagnostic tests, and has contributed to two malaria outbreaks in Peru. This investigation highlights the importance of accurate species diagnosis given the potential for P. falciparum to be reintroduced to regions where it may have been absent. Similar molecular epidemiological investigations can track the probable source(s) of outbreak parasite strains for malaria surveillance and control purposes.
Peru reported 43,468 malaria cases in 2013, 84% of which were attributed to Plasmodium vivax infection while 16% (7, 371) were due to Plasmodium falciparum. 1 As Peru and other South American countries progress toward the malaria pre-elimination phase, the utilization of appropriate parasite detection tools will facilitate effective disease surveillance and case management. Plasmodium falciparum transmission in Peru is mainly found in the Amazonic region; three departments (Loreto, San Martin, and Ucayali) reported P. falciparum malaria cases between January and the first week of December 2013. 2 Between 2010 and 2012, a P. falciparum malaria outbreak of 210 cases occurred in the north coastal department of Tumbes, where falciparum transmission had been interrupted for 5 years. 3 Using molecular tools, it was determined that a multidrug resistant, Pfhrp2 genedeleted lineage (B V1 ) originating from the Peruvian Amazon caused this outbreak. 3 Between November 1 and 20, 2013, 11 malaria cases occurred in two communities-Rosalina and Ivanqui (Palma Real)-in Echarate District, La Convención Province, Cusco Department, which is located in southern Peru. 2 Information about the 11 malaria-infected patients, eight males and three females, is presented in Table 1 . The community of Rosalina, where six malaria cases were detected, consisted of 70 families residing in 54 households whereas the community of Ivanqui, where five of the malaria-infected patients resided, had 92 families in 32 homes at the time of the malaria outbreak.
2 All 11 patients were initially found to be infected with P. vivax based on microscopic analysis and received a 7-day chloroquine (CQ) and primaquine (PQ) treatment regimen.
However, symptoms persisted in four of the patients, who then received CQ and PQ for 14 more days. The four patients continued to experience symptoms for over a month posttreatment until one of them visited a private practitioner on December 12, 2013. Microscopic examination of the patient's thick blood smear revealed P. falciparum infection. 2 Between
December 16 and 17, 2013, blood samples were obtained from the remaining three patients in whom symptoms had persisted after the initial P. vivax-targeted treatment. Giemsastained blood films were read by microscopy at which time the patients were confirmed to have P. falciparum malaria and treated with artesunate plus mefloquine. 2 Since 1946, only P. vivax malaria transmission had been reported in Cusco Department; all 608 malaria cases reported in 2013 were attributed to P. vivax.
2 For this reason, the P. falciparum diagnoses prompted active surveillance for febrile cases in Rosalina and Ivanqui. In addition, the 11 smears confirmed to be positive for P. vivax were reexamined and by December 2013, the Cusco Regional Directorate of Health confirmed that the malaria cases from Palma Real corresponded to a P. falciparum outbreak. 2 Blood samples from the four patients with persistent symptoms were sent to the Centers for Disease Control and Prevention malaria laboratory for further characterization. We determined the molecular profile (by genotyping microsatellites and drug-resistance-associated genes) of these four isolates and evaluated the possible origin(s) and/or relatedness to other P. falciparum parasite lineages previously reported in Peru. 4 Information about the four patients from whom the samples were collected is shown in Table 1 .
Neutral microsatellite markers were analyzed to delineate the genetic background of the parasites. 5, 6 Moreover, they were used to determine the source of a P. falciparum malaria outbreak in Tumbes.
four drug resistance-associated genes; Pfcrt (CQ resistance), Pfmdr1 (multidrug resistance), Pfdhfr (pyrimethamine resistance), and Pfdhps (sulfadoxine resistance) were polymerase chain reaction amplified and sequenced as described previously. 3 Finally, we genotyped histidine-rich protein 2 (Pfhrp2) and Pfhrp3 as reported by Akinyi and others. Pfhrp3. Overall, the genetic background of these isolates was identical to that of the B V1 lineage that caused the P. falciparum outbreak in Tumbes in 2012 (Figure 1 ). This finding suggests that the B V1 lineage is the most likely source of the falciparum malaria outbreak in Cusco. This is the second malaria outbreak in Peru that involved the same P. falciparum lineage.
It is important to point out that the B V1 lineage derived from the original "B clonal lineage" found in Peru since 1999. 5 The highly clonal dynamic observed in this P. falciparum population is the result of decreased outcrossing and genetic drift primarily resulting from inbreeding and asexual replication. 7 In general, the low P. falciparum genetic diversity found in South America relates to the low transmission intensity in this region. With fewer parasite types, there are limited opportunities for outcrossing during meiosis in the mosquito, which results in highly related or even clonal parasites. 8, 9 Moreover, since the P. falciparum population underwent strong drug selection, expansions of few drug-resistant parasite lineages is expected. 10 Epidemiological data suggest that the Cusco P. falciparum outbreak was the result of human migration from Loreto Department when a road construction company set up a camp in Rosalina to build a road to Kiteni, Echarate District. 2 In September 2013, prior to the outbreak, two road workers who were originally from Iquitos were diagnosed with severe malaria and, because of their critical condition, were subsequently transferred to another city for medical examination. It is suspected that these may have been the index cases to the ensuing outbreak. 2 Unfortunately, specimens from these suspected index cases were not available for molecular analysis to confirm the proposed link. Nevertheless, even with the limited number of samples analyzed, this molecular investigation corroborated the epidemiological data suggesting that the P. falciparum B V1 lineage from Loreto is the most likely source of the Cusco outbreak.
In addition to Peru, B V1 lineage parasites have been detected in isolates collected in Amazonas Department, Colombia, from as far back as 2005 11 ( Figure 2 ). Anopheles darlingi and Anopheles oswaldoi are the main malaria species in Amazonas Department. 12 The discovery of B V1 lineage parasites in other parts of the Amazon region of South America presents a major challenge for regional malaria control and elimination due to the persistence and wide distribution of this P. falciparum lineage, which seems highly adaptive to different transmission settings and can escape detection by PfHRP2-based rapid diagnostic tests because of Pfhrp2/ Pfhrp3 deletions.
Finally, this study highlights the need for local health posts to perform high-quality malaria diagnosis to detect P. falciparum introductions, particularly in areas where P. vivax transmission is known or thought to occur exclusively, because P. falciparum lineages could possibly establish themselves in the long term. In addition, although there have been some reports on the use and interpretation of Plasmodium molecular genetics tools for outbreak investigations, 3, 7 this methodology should be standardized for routine use to identify not only the Plasmodium species but the source(s) of a malaria outbreak and the prevalence of long-lasting drug-resistant P. falciparum strains. 
